Literature DB >> 28558855

High-quality fish oil has a more favourable effect than oxidised fish oil on intermediate-density lipoprotein and LDL subclasses: a randomised controlled trial.

Amanda Rundblad1, Kirsten B Holven2, Inger Ottestad2, Mari C Myhrstad1, Stine M Ulven2.   

Abstract

Fish oil (FO) supplementation reduces the risk of CVD. However, it is not known if FO of different qualities have different effects on lipoprotein subclasses in humans. We aimed at investigating the effects of oxidised FO and high-quality FO supplementation on lipoprotein subclasses and their lipid concentrations in healthy humans. In all, fifty-four subjects completed a double-blind randomised controlled intervention study. The subjects were randomly assigned to receive high-quality FO (n 17), oxidised FO (n 18) or high-oleic sunflower oil capsules (HOSO, n 19) for 7 weeks. The concentration of marine n-3 fatty acids was equal in high-quality FO and oxidised FO (1·6 g EPA+DHA/d). The peroxide value (PV) and anisidine value (AV) were 4 mEq/kg and 3 in high-quality FO and HOSO, whereas the PV and AV in the oxidised FO were 18 mEq/kg and 9. Blood samples were collected at baseline and end of study. NMR spectroscopy was applied for the analysis of lipoprotein subclasses and their lipid concentrations. High-quality FO reduced the concentration of intermediate-density lipoprotein (IDL) particles and large, medium and small LDL particles, as well as the concentrations of total lipids, phospholipids, total cholesterol, cholesteryl esters and free cholesterol in IDL and LDL subclasses compared with oxidised FO and HOSO. Hence, high-quality FO and oxidised FO differently affect lipid composition in lipoprotein subclasses, with a more favourable effect mediated by high-quality FO. In future trials, reporting the oxidation levels of FO would be useful.

Entities:  

Keywords:  AV anisidine value; CETP cholesteryl ester transfer protein; E% percentage of energy; FO fish oil; HOSO high-oleic sunflower oil capsules; IDL intermediate-density lipoprotein; PBMC peripheral blood mononuclear cells; PV peroxide value; Fish oil; LDL; Lipoprotein subclasses; Oxidised fish oil

Mesh:

Substances:

Year:  2017        PMID: 28558855     DOI: 10.1017/S0007114517001167

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

1.  Plasma fatty acid levels and gene expression related to lipid metabolism in peripheral blood mononuclear cells: a cross-sectional study in healthy subjects.

Authors:  Sunniva V Larsen; Kirsten B Holven; Inger Ottestad; Kine N Dagsland; Mari C W Myhrstad; Stine M Ulven
Journal:  Genes Nutr       Date:  2018-04-10       Impact factor: 5.523

Review 2.  Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with 'Normal' LDL-C Levels.

Authors:  Harold Superko; Brenda Garrett
Journal:  Biomedicines       Date:  2022-04-01

3.  Regular consumption of cod liver oil is associated with reduced basal and exercise-induced C-reactive protein levels; a prospective observational trial : A NEEDED (The North Sea Race Endurance Exercise Study) 2014 sub-study.

Authors:  Mette Wærstad Hansen; Stein Ørn; Christine B Erevik; Magnus Friestad Bjørkavoll-Bergseth; Øyvind Skadberg; Tor H Melberg; Kristin M Aakre; Øyunn Kleiven
Journal:  J Int Soc Sports Nutr       Date:  2021-06-28       Impact factor: 5.150

4.  Effects of krill oil and lean and fatty fish on cardiovascular risk markers: a randomised controlled trial.

Authors:  Amanda Rundblad; Kirsten B Holven; Inge Bruheim; Mari C Myhrstad; Stine M Ulven
Journal:  J Nutr Sci       Date:  2018-01-17

Review 5.  Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence.

Authors:  Samuel C R Sherratt; Michael Lero; R Preston Mason
Journal:  Curr Opin Lipidol       Date:  2020-04       Impact factor: 4.616

6.  Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development.

Authors:  Dongmei Wu; Qiuju Yang; Baohua Su; Jia Hao; Huirong Ma; Weilan Yuan; Junhui Gao; Feifei Ding; Yue Xu; Huifeng Wang; Jiangman Zhao; Bingqiang Li
Journal:  Front Cardiovasc Med       Date:  2021-04-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.